Yoshikazu Sakakima

Gene therapy for hepatocellular carcinoma using sonoporation enhanced by contrast agents

Yoshikazu Sakakima, Shuji Hayashi, Yoshikazu Yagi et al. · Cancer Gene Therapy · 2005 · 84 citations

Contrast Agents, Hepatology, In Vivo Gene Therapy +9

Prevention of hepatocarcinogenesis with phosphatidylcholine and menaquinone-4: In vitro and in vivo experiments

Yoshikazu Sakakima, Akemi Hayakawa, Tetsuro Nagasaka et al. · Journal of Hepatology · 2007 · 54 citations

Hepatology, Medicine, Liver Physiology +9

Auricular Acupuncture at the “Shenmen” and “Point Zero” Points Induced Parasympathetic Activation

Young‐Chang P. Arai, Yoshikazu Sakakima, Jun Kawanishi et al. · Evidence-based Complementary and Alternative Medicine · 2013 · 53 citations · Full text

The tumor suppressor NPRL2 in hepatocellular carcinoma plays an important role in progression and can be served as an independent prognostic factor

Satoshi Otani, Shin Takeda, Suguru Yamada et al. · Journal of Surgical Oncology · 2009 · 29 citations · Full text

Phosphatidylcholine induces growth inhibition of hepatic cancer by apoptosis via death ligands.

Yoshikazu Sakakima, Akemi Hayakawa, Akimasa Nakao · PubMed · 2009 · 21 citations